Rating Alert: What To Expect After PAREXEL (NASDAQ:PRXL)’s Downgrade Rating From Wells Fargo?

November 23, 2016 - By olga

Rating Alert: What To Expect After PAREXEL (NASDAQ:PRXL)'s Downgrade Rating From Wells Fargo?

PAREXEL (NASDAQ:PRXL) Downgrade

PAREXEL (NASDAQ:PRXL) was lowered by Wells Fargo from a “Outperform” rating to a “Market Perform” rating in a a report sent to clients and investors on Wednesday morning.

PAREXEL International Corporation (NASDAQ:PRXL) Ratings Coverage

Out of 11 analysts covering Parexel International (NASDAQ:PRXL), 2 rate it a “Buy”, 1 “Sell”, while 8 “Hold”. This means 18% are positive. $78 is the highest target while $49 is the lowest. The $65.71 average target is 14.12% above today’s ($57.58) stock price. Parexel International has been the topic of 21 analyst reports since August 7, 2015 according to StockzIntelligence Inc. Robert W. Baird upgraded the stock to “Outperform” rating in Friday, October 9 report. As per Friday, October 28, the company rating was maintained by Deutsche Bank. UBS downgraded the stock to “Neutral” rating in Tuesday, September 6 report. The firm has “Outperform” rating by Credit Suisse given on Friday, August 7. Deutsche Bank maintained it with “Hold” rating and $69 target price in Friday, August 7 report. Avondale maintained the shares of PRXL in a report on Monday, April 11 with “Underperform” rating. The stock has “Market Perform” rating given by Avondale on Wednesday, October 21. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has “Hold” rating given on Friday, November 11 by Suntrust Robinson. The rating was downgraded by SunTrust on Friday, November 11 to “Hold”. Credit Suisse initiated it with “Outperform” rating and $75 target price in Tuesday, June 21 report.

About 192,007 shares traded hands. PAREXEL International Corporation (NASDAQ:PRXL) has declined 12.36% since April 21, 2016 and is downtrending. It has underperformed by 17.69% the S&P500.

Insitutional Activity: The institutional sentiment decreased to 1 in Q2 2016. Its down 0.16, from 1.16 in 2016Q1. The ratio turned negative, as 31 funds sold all PAREXEL International Corporation shares owned while 96 reduced positions. 45 funds bought stakes while 102 increased positions. They now own 46.71 million shares or 2.30% less from 47.81 million shares in 2016Q1.

Kistler, a Alabama-based fund reported 1,000 shares. Roanoke Asset Mgmt Ny holds 1.49% or 51,046 shares in its portfolio. Paloma Ptnrs Management Co has 9,804 shares for 0.01% of their US portfolio. Ngam L P holds 0.02% or 19,985 shares in its portfolio. The Texas-based Stephens Management Grp Limited Company has invested 0.94% in PAREXEL International Corporation (NASDAQ:PRXL). Moreover, Sheets Smith Wealth Management has 0.09% invested in PAREXEL International Corporation (NASDAQ:PRXL) for 5,032 shares. Plante Moran Finance Advsrs Lc last reported 37 shares in the company. Schroder Invest Mngmt Grp Inc has invested 0.11% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL). Spark Inv Mgmt Lc has invested 0.24% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL). Us Commercial Bank De accumulated 0.01% or 40,918 shares. Ny State Teachers Retirement System, a New York-based fund reported 101,803 shares. Voya Invest Limited Liability Co holds 0% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL) for 23,447 shares. Investment Mngmt Of Virginia Ltd Liability Com, a Virginia-based fund reported 14,815 shares. The New York-based Eulav Asset Management has invested 0.29% in PAREXEL International Corporation (NASDAQ:PRXL). Tudor Inv Et Al last reported 4,800 shares in the company.

Insider Transactions: Since May 24, 2016, the stock had 0 insider purchases, and 4 insider sales for $570,931 net activity. Schultz Joshua had sold 2,500 shares worth $171,600. Holdener Eduard E. also sold $44,086 worth of PAREXEL International Corporation (NASDAQ:PRXL) on Thursday, June 2. $465,000 worth of PAREXEL International Corporation (NASDAQ:PRXL) was sold by SCHNEIDER ULF I. CALLOW A DANA JR also sold $180,120 worth of PAREXEL International Corporation (NASDAQ:PRXL) on Monday, June 13. Another trade for 2,500 shares valued at $175,125 was made by Saarony Gadi on Monday, August 15.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has a market cap of $3.12 billion. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. It has a 18.41 P/E ratio. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

According to Zacks Investment Research, “Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.”

PRXL Company Profile

PAREXEL International Corporation (PAREXEL), incorporated on January 3, 1983, is a biopharmaceutical outsourcing services company. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

More notable recent PAREXEL International Corporation (NASDAQ:PRXL) news were published by: Businesswire.com which released: “PAREXEL International Announces $200 Million Accelerated Share Repurchase Program” on November 22, 2016, also Fool.com with their article: “PAREXEL International Corporation’s Q1 Report Flops, Shares Sink As Much As 13%” published on October 27, 2016, Prnewswire.com published: “SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of …” on November 11, 2016. More interesting news about PAREXEL International Corporation (NASDAQ:PRXL) were released by: Businesswire.com and their article: “Bragar Eagel & Squire, P.C. Is Investigating PAREXEL International Corporation …” published on November 14, 2016 as well as Bizjournals.com‘s news article titled: “Parexel loses $160M in value after disclosing possible embezzlement” with publication date: September 01, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>